Human Papillomavirus (HPV) is the most common sexually transmitted infection. Its progression is related to the development of malignant lesions, particularly cervical intraepithelial neoplasias (CINs). CINs correlate with a higher risk of premature births, and their excisional and ablative treatment further increases this risk in pregnant women. These complications are also correlated with higher healthcare costs for their management. In Italy, more than 26,000 new cases of CINs are estimated to occur yearly and their economic burden is significant. Therefore, the management of these conditions is a public health priority. Since HPV vaccination is associated with a reduced risk of relapse in women surgically treated for HPV-related injuries, we estimated the economic impact of extending HPV vaccination to this target population. This strategy would result in a significant reduction in the general costs of managing these women, resulting in an overall saving for the Italian Health Service of € 155,596.38 in 5 years. This lower cost is due not only to the reduced incidence of CINs following vaccination, but also to the lower occurrence of preterm births. Extending HPV vaccination to this target population as part of a care path to be offered to women treated for HPV injuries is therefore desirable.

Basile, M., Calabro, G. E., Ghelardi, A., Ricciardi, R., De Vincenzo, R., Cicchetti, A., Hpv vaccination in women treated for cervical intraepithelial neoplasia: A budget impact analysis, <<VACCINES>>, 2021; 9 (8): 816-829. [doi:10.3390/vaccines9080816] [http://hdl.handle.net/10807/201205]

Hpv vaccination in women treated for cervical intraepithelial neoplasia: A budget impact analysis

Basile, M.;Calabro, G. E.
Co-primo
Conceptualization
;
De Vincenzo, R.;Cicchetti, A.
2021

Abstract

Human Papillomavirus (HPV) is the most common sexually transmitted infection. Its progression is related to the development of malignant lesions, particularly cervical intraepithelial neoplasias (CINs). CINs correlate with a higher risk of premature births, and their excisional and ablative treatment further increases this risk in pregnant women. These complications are also correlated with higher healthcare costs for their management. In Italy, more than 26,000 new cases of CINs are estimated to occur yearly and their economic burden is significant. Therefore, the management of these conditions is a public health priority. Since HPV vaccination is associated with a reduced risk of relapse in women surgically treated for HPV-related injuries, we estimated the economic impact of extending HPV vaccination to this target population. This strategy would result in a significant reduction in the general costs of managing these women, resulting in an overall saving for the Italian Health Service of € 155,596.38 in 5 years. This lower cost is due not only to the reduced incidence of CINs following vaccination, but also to the lower occurrence of preterm births. Extending HPV vaccination to this target population as part of a care path to be offered to women treated for HPV injuries is therefore desirable.
Inglese
Basile, M., Calabro, G. E., Ghelardi, A., Ricciardi, R., De Vincenzo, R., Cicchetti, A., Hpv vaccination in women treated for cervical intraepithelial neoplasia: A budget impact analysis, <<VACCINES>>, 2021; 9 (8): 816-829. [doi:10.3390/vaccines9080816] [http://hdl.handle.net/10807/201205]
File in questo prodotto:
File Dimensione Formato  
Basile, Calabrò, 2021.pdf

accesso aperto

Tipologia file ?: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 568.55 kB
Formato Adobe PDF
568.55 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/201205
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact